FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950248967> ?p ?o ?g. }

• W2950248967 endingPage "1365" @default.
• W2950248967 startingPage "1360" @default.
• W2950248967 abstract "Abstract Psoriasis is a chronic, recurrent, inflammatory, and proliferative skin disease. Its etiology has not yet been fully assessed, but undoubtedly it is a multifaceted disease. The key role in its pathomechanism is played by genetic, immunologic, and environmental factors and stress. If traditional methods of psoriasis treatment (phototherapy, methotrexate, retinoids, cyclosporine A) fail, we reach for the following biopharmaceuticals – infliximab, etanercept, adalimumab, or ustekinumab. However, genetic engineering progress discovers new possibilities – the pending clinical trials involve IL ‐17, IL ‐23 antagonists, PDE 4 and ‐3 and ‐1. Psoriasis etiopathogenesis mainly involves the IL ‐17A, IL ‐17F, and IL ‐17A/F subtypes, which affect the keratinocytes. The biological therapy molecularly oriented with the antagonists of interleukin 17 is based mainly on the influence onto the cytokine in the manner that prevents it from binding with the receptor. Three biopharmaceuticals are currently under third phase studies: two fully humanized antibodies neutralizing IL ‐17 – ixekizumab and secukinumab, and one human monoclonal antibody, brodalumab. The below work will be devoted to the analysis of possible undesirable symptoms, which were observed during the studies. We will try to review the latest literature concerning the most important clinical trials conducted in many centers." @default.
• W2950248967 created "2019-06-27" @default.
• W2950248967 creator A5027458970 @default.
• W2950248967 creator A5033113181 @default.
• W2950248967 creator A5075009911 @default.
• W2950248967 creator A5086505040 @default.
• W2950248967 creator A5087113902 @default.
• W2950248967 date "2019-06-13" @default.
• W2950248967 modified "2023-10-18" @default.
• W2950248967 title "Are new variants of psoriasis therapy ( IL ‐17 inhibitors) safe?" @default.
• W2950248967 cites W1845936179 @default.
• W2950248967 cites W1850524624 @default.
• W2950248967 cites W2024249616 @default.
• W2950248967 cites W2029763593 @default.
• W2950248967 cites W2040164730 @default.
• W2950248967 cites W2055577285 @default.
• W2950248967 cites W2062064600 @default.
• W2950248967 cites W2062801585 @default.
• W2950248967 cites W2068133062 @default.
• W2950248967 cites W2101586009 @default.
• W2950248967 cites W2103750969 @default.
• W2950248967 cites W2107432039 @default.
• W2950248967 cites W2122003518 @default.
• W2950248967 cites W2276035339 @default.
• W2950248967 cites W2318411520 @default.
• W2950248967 cites W2336283515 @default.
• W2950248967 cites W2499208291 @default.
• W2950248967 cites W2529389767 @default.
• W2950248967 cites W2530872160 @default.
• W2950248967 cites W2586643098 @default.
• W2950248967 cites W2620369605 @default.
• W2950248967 cites W2740681317 @default.
• W2950248967 cites W2752721387 @default.
• W2950248967 cites W2754104556 @default.
• W2950248967 doi "https://doi.org/10.1111/ijd.14509" @default.
• W2950248967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31192456" @default.
• W2950248967 hasPublicationYear "2019" @default.
• W2950248967 type Work @default.
• W2950248967 sameAs 2950248967 @default.
• W2950248967 citedByCount "6" @default.
• W2950248967 countsByYear W29502489672019 @default.
• W2950248967 countsByYear W29502489672020 @default.
• W2950248967 countsByYear W29502489672021 @default.
• W2950248967 countsByYear W29502489672022 @default.
• W2950248967 crossrefType "journal-article" @default.
• W2950248967 hasAuthorship W2950248967A5027458970 @default.
• W2950248967 hasAuthorship W2950248967A5033113181 @default.
• W2950248967 hasAuthorship W2950248967A5075009911 @default.
• W2950248967 hasAuthorship W2950248967A5086505040 @default.
• W2950248967 hasAuthorship W2950248967A5087113902 @default.
• W2950248967 hasConcept C126322002 @default.
• W2950248967 hasConcept C159654299 @default.
• W2950248967 hasConcept C16005928 @default.
• W2950248967 hasConcept C17991360 @default.
• W2950248967 hasConcept C203014093 @default.
• W2950248967 hasConcept C2776260265 @default.
• W2950248967 hasConcept C2777138892 @default.
• W2950248967 hasConcept C2777226972 @default.
• W2950248967 hasConcept C2778690821 @default.
• W2950248967 hasConcept C2778975655 @default.
• W2950248967 hasConcept C2779134260 @default.
• W2950248967 hasConcept C2779745271 @default.
• W2950248967 hasConcept C2779786854 @default.
• W2950248967 hasConcept C2780132546 @default.
• W2950248967 hasConcept C2780564577 @default.
• W2950248967 hasConcept C2781228260 @default.
• W2950248967 hasConcept C47348012 @default.
• W2950248967 hasConcept C535046627 @default.
• W2950248967 hasConcept C542903549 @default.
• W2950248967 hasConcept C71924100 @default.
• W2950248967 hasConceptScore W2950248967C126322002 @default.
• W2950248967 hasConceptScore W2950248967C159654299 @default.
• W2950248967 hasConceptScore W2950248967C16005928 @default.
• W2950248967 hasConceptScore W2950248967C17991360 @default.
• W2950248967 hasConceptScore W2950248967C203014093 @default.
• W2950248967 hasConceptScore W2950248967C2776260265 @default.
• W2950248967 hasConceptScore W2950248967C2777138892 @default.
• W2950248967 hasConceptScore W2950248967C2777226972 @default.
• W2950248967 hasConceptScore W2950248967C2778690821 @default.
• W2950248967 hasConceptScore W2950248967C2778975655 @default.
• W2950248967 hasConceptScore W2950248967C2779134260 @default.
• W2950248967 hasConceptScore W2950248967C2779745271 @default.
• W2950248967 hasConceptScore W2950248967C2779786854 @default.
• W2950248967 hasConceptScore W2950248967C2780132546 @default.
• W2950248967 hasConceptScore W2950248967C2780564577 @default.
• W2950248967 hasConceptScore W2950248967C2781228260 @default.
• W2950248967 hasConceptScore W2950248967C47348012 @default.
• W2950248967 hasConceptScore W2950248967C535046627 @default.
• W2950248967 hasConceptScore W2950248967C542903549 @default.
• W2950248967 hasConceptScore W2950248967C71924100 @default.
• W2950248967 hasIssue "12" @default.
• W2950248967 hasLocation W29502489671 @default.
• W2950248967 hasLocation W29502489672 @default.
• W2950248967 hasOpenAccess W2950248967 @default.
• W2950248967 hasPrimaryLocation W29502489671 @default.
• W2950248967 hasRelatedWork W1970925217 @default.
• W2950248967 hasRelatedWork W2202409929 @default.
• W2950248967 hasRelatedWork W2591728499 @default.

• next